Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - Lexaria Bioscience Corp.exhibit99-1.htm
8-K - FORM 8-K - Lexaria Bioscience Corp.form8k.htm

October 6, 2016
 
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street NE
Washington, DC 20549
 
Dear Sir/Madam:

We have read the statements under item 4.01 in the Form 8-K dated October 6, 2016 of Lexaria

Bioscience Corp. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.

Yours truly,


Jenny Lee, CPA, CA
Assurance Partner